Solution Brief: Scalable Lab Adherence & Real-Time Safety Oversight for High Risk Therapies
Turn Complex Safety Monitoring Into a Competitive Advantage
Specialty therapies with strict lab monitoring requirements often create operational complexity that providers avoid.
Manual coordination leads to missed collections, delayed safety insights, and increased burden on care teams.
The result: reduced prescribing confidence and slower adoption.
Leading pharma teams are solving this with automated, coordinated safety monitoring infrastructure.
Download the Solution Brief to see how.
1.2+ Million Labs Monitored to Date
Pharma Teams are Moving Toward Coordinated Monitoring Infrastructure
Rather than relying on fragmented workflows between labs, providers, and PSPs, leading organizations are implementing orchestrated safety monitoring programs that connect the entire care ecosystem enabling:
✓ Real-time visibility into patient adherence
✓ Automated detection of missed or abnormal lab results
✓ Reduced administrative burden for care teams
✓ How pharmaceutical companies operationalize lab monitoring programs at scale
✓ Infrastructure required for real-time therapy safety monitoring
✓ Strategies to improve lab adherence for specialty therapies
✓ How automated monitoring reduces provider burden and prescribing friction
✓ Real-world program outcomes across thousands of monitored labs
The Results
%
adherence in trials
%
adherence in real-world settings
higher compliance
adherence in trials
adherence in real-world settings
higher compliance
Discover How Scalable Safety Monitoring
Is a Competitive Advantage
Download our solution brief to learn how RxPx helps pharmaceutical companies implement automated lab monitoring programs
that support therapy adoption while protecting patients.